De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sue S Yom
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
494 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Ais Cancer Center at San Joaquin Community Hospital
Bakersfield, California, United States
- Tower Cancer Research Foundation
Beverly Hills, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Uc San Diego Health System - Encinitas
Encinitas, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Fresno Cancer Center
Fresno, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- City of Hope at Irvine Lennar
Irvine, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California, United States
- Kaiser Permanente- Marshall Medical Offices
Redwood City, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
- Rohnert Park Cancer Center
Rohnert Park, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- the Permanente Medical Group-Roseville Radiation Oncology
Roseville, California, United States
- Kaiser Permanente Downtown Commons
Sacramento, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Oct 2019
- Primary completion
- 1 Mar 2024
- Completion
- 11 Dec 2026
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 384
- Registry id
- NCT03952585
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.